Publikacje

2005-2023

  1. Kopa-Stojak P, Pawliczak R. Comparison of effects of tobacco cigarettes, electronic nicotine delivery systems and tobacco heating products on miRNA-mediated gene expression. A systematic review, Toxicology Mechanisms and Methods, (2023); 33:1.
  2. Tatka A, Pawliczak R. Skin manifestations associated with COVID-19. Alergologia Polska – Polish Journal of Allergology. 2022;9(3):143-149.
  3. Tatka A, Pawliczak R. The role of diet in atopic dermatitis. Alergologia Polska – Polish Journal of Allergology. 2022;9(2):99-105.
    4. Kowalczyk T, Sitarek P, Śliwiński T, Hatziantoniou S, Soulintzi N, Pawliczak R, Wieczfinska J. New Data on Anti-Inflammatory and Wound Healing Potential of Transgenic Senna obtusifolia Hairy Roots: In Vitro Studies. International Journal of Molecular Sciences. 2023; 24(6):5906.
    1. Sitarek P, Kowalczyk T, Śliwiński T, Hatziantoniou S, Soulintzi N, Pawliczak R, Wieczfinska J. Leonotis nepetifolia Transformed Root Extract Reduces Pro-Inflammatory Cytokines and Promotes Tissue Repair In Vitro. International Journal of Environmental Research and Public Health. 2023; 20(6):4706.
    2. Wieczfinska, J, Sitarek, P, Kowalczyk, T, Rieske, P, Pawliczak, R. Curcumin modulates airway remodelling-contributing genes—the significance of transcription factors. J Cell Mol Med. 2022; 26: 736– 749.
    3. Wieczfinska J, Pawliczak R. Relaxin Affects Airway Remodeling Genes Expression through Various Signal Pathways Connected with Transcription Factors. International Journal of Molecular Sciences. 2022; 23(15):8413.
    4. Pawliczak R, Emeryk A, Kupczyk M, Chorostowska-Wynimko J, Kuna P, Kulus M. Guidelines for asthma diagnosis and treatment Polish Society of Allergology, Polish Society of Lung Diseases and Polish Society of Family Medicine (STAN3T). Alergologia Polska – Polish Journal of Allergology. 2023;10(1):1-14.
    5. Lorenz D, Pawliczak R. Oral anti-COVID-19 drugs that were recently evaluated by FDA or EMA: a review. Alergologia Polska – Polish Journal of Allergology. 2022;9(1):33-40.
    6. Nowak A, Pawliczak R. Cigarette smoking and oxidative stress. Alergologia Polska – Polish Journal of Allergology. 2022;9(2):89-98.
    7. Hoffmann A, Strózik T, Wasiak T, Buczyłko K, Pawliczak R. Compositional differences between gut microbiota of adult patients with asthma and healthy controls. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(1):142-149.
    8. Kleniewska, P., Pawliczak, R. Does Oxidative Stress Along with Dysbiosis Participate in the Pathogenesis of Asthma in the Obese?. Cell Biochem Biophys 81, 117–126 (2023).
    9. Skalska M, Kleniewska P, Pawliczak R. Participation of reactive oxygen species in the pathogenesis of atopic dermatitis, allergic rhinitis and asthma. Alergologia Polska – Polish Journal of Allergology. 2023;10(1):26-31.
    10. Wieczfinska J, Kleniewska P, Pawliczak R. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections”, Oxidative Medicine and Cellular Longevity, vol. 2022, Article ID 5589089, 15 pages, 2022.
    11. Sobczak M, Pawliczak R. Does Vitamin D Work Synergistically with Anti-Asthmatic Drugs in Airway Remodeling? International Journal of Molecular Sciences. 2022; 23(21):12798.
    12. Sobczak M, Pawliczak R. Factors That Affect the COVID-19 Pandemic in Summer 2022 Compared to Summer 2021. International Journal of Environmental Research and Public Health. 2022; 19(19):12561.
    13. Sobczak, M., Pawliczak, R. COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials. Ann Clin Microbiol Antimicrob 21, 32 (2022).
    14. Sobczak, M., Pawliczak, R. COVID-19 mortality rate determinants in selected Eastern European countries. BMC Public Health 22, 2088 (2022).
    15. Kowalczyk, T.; Merecz-Sadowska, A.; Picot, L.; Brčić Karačonji, I.; Wieczfinska, J.; Śliwiński, T.; Sitarek, P. Genetic Manipulation and Bioreactor Culture of Plants as a Tool for Industry and Its Applications. Molecules 2022, 27, 795.
    16. Sobczak M, Pawliczak R. The risk of anaphylaxis behind authorized COVID-19 vaccines: a meta-analysis. Clin Mol Allergy. 2022 Jan 17;20(1):1.
    17. Wieczfinska J, Sitarek P, Kowalczyk T, Rieske P, Pawliczak R. Curcumin modulates airway remodelling-contributing genes-the significance of transcription factors. J Cell Mol Med. 2021 Dec 23.
    18. Nowak A, Pawliczak R. Comparison of the harmfulness of smoking tobacco cigarettes versus heat-not-burn tobacco in patients with asthma. Alergologia Polska – Polish Journal of Allergology. 2021;8(2):72-76.
    19. Pietrusiewicz M, Kopa-Stojak PN, Pawliczak R. Pharmacist’s recommendations of over-the-counter treatments for the common cold – analysis of prospective cases in Poland. BMC Fam Pract. 2021 Oct 30;22(1):216.
    20. Marko M, Pawliczak R. Can we safely use systemic treatment in atopic dermatitis during the COVID-19 pandemic? Overview of selected conventional and biologic systemic therapies. Expert Rev Clin Immunol. 2021 Jun;17(6):619-627.
    21. Hoffmann A, Kleniewska P, Pawliczak R. Antioxidative activity of probiotics. Arch Med Sci. 2019 Nov 21;17(3):792-804.
    22. Pniewska-Dawidczyk E, Kupryś-Lipińska I, Turek G, Kacprzak D, Wieczfinska J, Kleniewska P, Kuna P, Pawliczak R. Expression of cPLA2γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen. Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:2058738421990952.
    23. Banasiak H, Pawliczak R. Clinical profile of chronic bronchial asthma patients in Poland: results of the PROKSAL study. Postepy Dermatol Alergol. 2020 Dec;37(6):879-889.
    24. Kopa PN, Pawliczak R. Menthol additives to tobacco products. Reasons for withdrawing mentholated cigarettes in European Union on 20th may 2020 according to tobacco products directive (2014/40/EU). Toxicol Mech Methods. 2020 Oct;30(8):555-561.
    25. Wieczfinska J, Sitarek P, Kowalczyk T, Pawliczak R. Leonurus sibiricus root extracts decrease airway remodeling markers expression in fibroblasts. Clin Exp Immunol. 2020 Oct;202(1):28-46.
    26. Marko M, Pawliczak R. Real-life efficiency and safety comparison study of emollient ointment based on glycerophosphoinositol (GPI) salt of choline and other emollient products in patients with atopic dermatitis. J Dermatolog Treat. 2020 Aug 4:1-12.
    27. Sitarek P, Merecz-Sadowska A, Kowalczyk T, Wieczfinska J, Zajdel R, Śliwiński T. Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms. Int J Mol Sci. 2020 Jul 19;21(14):5105.
    28. Sitarek P, Toma M, Ntungwe E, Kowalczyk T, Skała E, Wieczfinska J, Śliwiński T, Rijo P. Insight the Biological Activities of Selected Abietane Diterpenes Isolated from Plectranthus spp. Biomolecules. 2020 Jan 28;10(2):194.
    29. Sitarek P, Kowalczyk T, Wieczfinska J, Merecz-Sadowska A, Górski K, Śliwiński T, Skała E. Plant Extracts as a Natural Source of Bioactive Compounds and Potential Remedy for the Treatment of Certain Skin Diseases. Curr Pharm Des. 2020;26(24):2859-2875.
    30. Kowalczyk T, Wieczfinska J, Skała E, Śliwiński T, Sitarek P. Transgenesis as a Tool for the Efficient Production of Selected Secondary Metabolites from in Vitro Plant Cultures. Plants (Basel). 2020 Jan 21;9(2):132.
    31. Wieczfinska J, Sitarek P, Kowalczyk T, Skała E, Pawliczak R. The anti-inflammatory potential of selected plant-derived compounds in respiratory diseases. Curr Pharm Des. 2020.
    32. Szymczak-Pajor I, Pawliczak R. Comparison of an automated microfluidic immunoassay technology (BioIC, lab-on-chips) and ImmunoCAP assay. Lab-on-chips as a tool for specific IgE (sIgE) detection. Postepy Dermatol Alergol. 2020;37(1):56‐60.
    33. Skała E, Makowczyńska J, Wieczfinska J, Kowalczyk T, Sitarek P. Caffeoylquinic Acids with Potential Biological Activity from Plant In vitro Cultures as Alternative Sources of Valuable Natural Products. Curr Pharm Des. 2020;26(24):2817-2842.
    34. Zyma M, Pawliczak R. Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response. Int Rev Immunol. 2020;39(3):97‐117.
    35. Szymczak-Pajor I, Kleniewska P, Wieczfinska J, Pawliczak R. Wide-Range Effects of 1,25(OH)2D3 on Group 4A Phospholipases Is Related to Nuclear Factor κ-B and Phospholipase-A2 Activating Protein Activity in Mast Cells. Int Arch Allergy Immunol. 2020;181(1):56‐70.
    36. Kopa PN, Pawliczak R. IQOS – a heat-not-burn (HnB) tobacco product – chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review. Toxicol Mech Methods. 2020;30(2):81‐87.
    37. Kopa P., Macieja A., Gulbas I., Pastwa E., Poplawski T. Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells. Mol Biol Rep. 2020; 47, 67-76.
    38. Macieja A., Kopa P., Galita G., Pastwa E., Majsterek I., Popławski T. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors. Mol Biol Rep. 2019; 46(4).
    39. Łabędź N, Pawliczak R. Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials. Postepy Dermatol Alergol. 2019;36(6):752‐759.
    40. Marko M, Pawliczak R. How to interpret the results of comparative drug tests? Statistical analysis methods: standardized SMD mean difference and mean difference calculated by the LSMD least squares method. Polish Journal of Allergology. 2019;6,3: 90–99.
    41. Marko M, Pawliczak R. Noninferiority trials in clinical practice. Polish Journal of Allergology. 2019;6,4: 152–159.
    42. Wieczfinska J, Sitarek P, Skała E, Kowalczyk T, Pawliczak R. Inhibition of NADPH Oxidase-Derived Reactive Oxygen Species Decreases Expression of Inflammatory Cytokines in A549 Cells [published correction appears in Inflammation. 2020 Feb 11;:]. Inflammation. 2019;42(6):2205‐2214.
    43. Kleniewska P, Pawliczak R. The influence of apocynin, lipoic acid and probiotics on antioxidant enzyme levels in the pulmonary tissues of obese asthmatic mice. Life Sci. 2019;234:116780.
    44. Marko M, Pawliczak R. How to interpret the results of comparative drug tests? Statistical analysis methods: standardized SMD mean difference and mean difference calculated by the LSMD least squares method. Polish Journal of Allergology. 2019;6,3: 90–99.
    45. Marko M, Pawliczak R. Noninferiority trials in clinical practice. Polish Journal of Allergology. 2019;6,4: 152–159
    46. Kopa PN, Pawliczak R. Health consequences of smoking – focusing on alternative smoking methods. Alergologia Polska – Polish Journal of Allergology. 2019. 3(6): 100-109. doi: 10.5114/pja.2019.88291.
    47. Wieczfińska J, Kowalczyk T, Sitarek P, Skała E, Pawliczak R. Analysis of short-term smoking effects in PBMC of healthy subjects-preliminary study. Int J Environ Res Public Health. 2018;  May 18;15(5).
    48. Kleniewska P, Pawliczak R. Assessment of human 4-hydroxynonenal, 8-isoprostane concentrations and glutathione reductase activity after synbiotics administration. Adv Med Sci. 2018 Sep;63(2):301-305.
    49. Kopa P., Macieja A., Galita G., Witczak ZJ., Poplawski T. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics. Curr Med Chem. 2018 Feb 13.
    50. Szymczak I, Pawliczak R. Can vitamin D help in achieving asthma control? Vitamin D „revisited”: an updated insight. Adv Respir Med 2018;86(2):103-109.
    51. Kopa P, Pawliczak R. Effect of smoking on gene expression profile – overall mechanism, impact on respiratory system function, and reference to electronic cigarettes. Toxicol Mech Methods. 2018 Jul;28(6):397-409.
    52. Marko M, Pawliczak R. Obesity and asthma: risk, control and treatment. Postepy Dermatol Alergol. 2018 Dec;35(6):563-571.
    53. Szymczak-Pajor I, Pawliczak R.  Adipose tissue as a potential source of hormones and cytokines involved in asthma pathogenesis. Alergol Pol. 2017. Vol.4. 132-138.
    54. Żebrowska A, Woźniacka A, Juczyńska K, Ociepa K, Waszczykowska E, Szymczak I, Pawliczak R. Correlation between IL-36α and IL -17 and activity of the disease in selected autoimmune blistering diseases. Mediators Inflamm. 2017;2017:8980534.
    55. Juczyńska K, Woźniacka A, Waszczykowska E, Danilewicz M, Wagrowska-Danilewicz M, Wieczfinska J, Pawliczak R, Żebrowska A.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis. Mediators Inflamm. 2017;2017:6716419.
    56. Kleniewska P, Pawliczak R. Influence of Synbiotics on Selected Oxidative Stress Parameters. Oxid Med Cell Longev. 2017;2017:9315375.
    57. Kleniewska P, Pawliczak R. The participation of oxidative stress in the pathogenesis of bronchial asthma. Biomed Pharmacother. 2017 Oct;94:100-108.
    58. Marko M, Pawliczak R. The role of microbiota in allergy development. Alergol Pol. 2017; Vol. 4 (2); 58-62.
    59. Wieczfińska J, Pawliczak R. Thymic stromal lymphopoietin and apocynin alter the expression of airway remodeling factors in human rhinovirus-infected cells. Immunobiology. 2017 Aug;222(8-9):892-899.
    60. Luczak E, Wieczfinska J, Sokolowska M, Pniewska E, Luczynska D, Pawliczak R. Troglitazone, a PPAR-gamma agonist, decreases LTC4 concentration in mononuclear cells in patients with asthma. Pharmacol Rep. 2017 Dec;69(6):1315-1321.
    61. Kleniewska P, Hoffmann A, Pniewska E, Pawliczak R. The Influence of Probiotic Lactobacillus casei in Combination with Prebiotic Inulin on the Antioxidant Capacity of Human Plasma. Oxid Med Cell Longev. 2016;2016:1340903.
    62. Szymczak I, Pawliczak R. The Active Metabolite of Vitamin D3 as a Potential Immunomodulator. Scand J Immunol. luty 2016;83(2):83–91.
    63. Wieczfinska J, Kacprzak D, Pospiech K, Sokolowska M, Nowakowska M, Pniewska E, i in. The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge. Respir Res. 2015;16(1):147.
    64. Kacprzak D, Pawliczak R. Does aspirin-induced oxidative stress cause asthma exacerbation? Arch Med Sci AMS. 19 czerwiec 2015;11(3):494–504.
    65. Pniewska E, Sokolowska M, Kupryś-Lipińska I, Kacprzak D, Kuna P, Pawliczak R. Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and healthy subjects. Int Arch Allergy Immunol. 2014;165(4):229–43.
    66. Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M, Wieczfinska J, Pniewska E, Zebrowski M, i in. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases. Mediators Inflamm. 2015;2015:870428.
    67. Pniewska E, Sokolowska M, Kupryś-Lipińska I, Przybek M, Kuna P, Pawliczak R. The step further to understand the role of cytosolic phospholipase A2 alpha and group X secretory phospholipase A2 in allergic inflammation: pilot study. BioMed Res Int. 2014;2014:670814.
    68. Winiecka-Klimek M, Szybka M, Rieske P, Piaskowski S, Bienkowski M, Walczak M, i in. PIN3 duplication may be partially responsible for TP53 haploinsufficiency. BMC Cancer. 2014;14:669.
    69. Wieczfinska J, Sokolowska M, Pawliczak R. NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation? Antioxid Redox Signal. 10 sierpień 2015;23(5):428–45.
    70. Pniewska E, Pawliczak R. The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease. Mediators Inflamm. 2013;2013:793505.
    71. Mokrowiecka A, Sokolowska M, Luczak E, Dudojc M, Wieczfinska J, Kacprzak D, i in. Adiponectin and leptin receptors expression in Barrett’s esophagus and normal squamous epithelium in relation to central obesity status. J Physiol Pharmacol Off J Pol Physiol Soc. kwiecień 2013;64(2):193–9.
    72. Pawliczak R. New horizons in allergy diagnostics and treatment. Pol Arch Med Wewnętrznej. 2013;123(5):246–50.
    73. Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M, Sokolowska M, Stasikowska-Kawecka O, Erkiert-Polguj A, i in. Does Adam17 cause the destruction of anchoring fibers via shedding tumor necrosis factor α in bullous pemphigoid and dermatitis herpetiformis? J Cutan Med Surg. czerwiec 2012;16(3):149–50.
    74. Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Doniec Z, Bialasiewicz P, i in. Hydrogen peroxide and nitrite reduction in exhaled breath condensate of COPD patients. Pulm Pharmacol Ther. październik 2012;25(5):343–8.
    75. Stefanska J, Sarniak A, Wlodarczyk A, Sokolowska M, Pniewska E, Doniec Z, i in. Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics. Exp Lung Res. marzec 2012;38(2):90–9.
    76. Adamusiak AM, Stasikowska-Kanicka O, Lewandowska-Polak A, Danilewicz M, Wagrowska-Danilewicz M, Jankowski A, i in. Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. Int Arch Allergy Immunol. 2012;157(4):354–62.
    77. Lesiak A, Narbutt J, Wodz K, Pawliczak R, Rogowski-Tylman M, Sysa-Jedrzejowska A, i in. Repeated suberythemal UVB preexposure protects against high-dose UVB-induced expression of vitamin D receptor protein in human Skin. J Invest Dermatol. listopad 2011;131(11):2332–5.
    78. Lesiak A, Norval M, Wodz-Naskiewicz K, Pawliczak R, Rogowski-Tylman M, Sysa-Jedrzejowska A, i in. An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp Dermatol. październik 2011;20(10):800–4.
    79. Sokolowska M, Stefanska J, Wodz-Naskiewicz K, Pawliczak R. Cytosolic phospholipase A2 group IVA influence on GM-CSF expression in human lung cells: a pilot study. Med Sci Monit Int Med J Exp Clin Res. wrzesień 2010;16(9):BR300-306.
    80. Sokolowska M, Stefanska J, Wodz-Naskiewicz K, Cieslak M, Pawliczak R. Cytosolic phospholipase A2 group IVA is overexpressed in patients with persistent asthma and regulated by the promoter microsatellites. J Allergy Clin Immunol. czerwiec 2010;125(6):1393–5.
    81. Sokolowska M, Wodz-Naskiewicz K, Cieslak M, Seta K, Bednarek AK, Pawliczak R. Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes. BMC Immunol. 2009;10:63.
    82. Stefanska J, Sokolowska M, Sarniak A, Wlodarczyk A, Doniec Z, Nowak D, i in. Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects. Pulm Pharmacol Ther. luty 2010;23(1):48–54.
    83. Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M, Wodz K, Sokolowska M, Erkiert-Polguj A, i in. Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis. J Dermatol Sci. październik 2009;56(1):58–61.
    84. Zebrowska A, Waszczykowska E, Wagrowska-Danilewicz M, Danilewicz M, Erkiert-Polguj A, Pawliczak R, i in. Expression of selected adhesion molecules in dermatitis herpetiformis and bullous pemphigoid. Pol J Pathol Off J Pol Soc Pathol. 2009;60(1):26–34.
    85. Wódz-Naskiewicz K, Pawliczak R. [Cysteinyl leukotrienes and their receptors]. Postepy Biochem. 2009;55(4):395–405.
    86. Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm. 2008;2008:106507.
    87. Jaworek R, Pawliczak R, Miedzobrodzki J. [Recent opinions on the role of acidophilic granulocytes in mechanisms of immunological defence and in pathogenesis of selected human diseases]. Folia Med Cracov. 2008;49(3–4):13–22.
    88. Sokolowska M, Borowiec M, Ptasinska A, Cieslak M, Shelhamer JH, Kowalski ML, i in. 85-kDa cytosolic phospholipase A2 group IValpha gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study. Clin Exp Immunol. październik 2007;150(1):124–31.
    89. Kowalski ML, Borowiec M, Kurowski M, Pawliczak R. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release. Allergy. czerwiec 2007;62(6):628–34.
    90. Lewandowicz AM, Pawliczak R. [Arginine metabolism in bronchial asthma]. Postȩpy Hig Med Dośw Online. 2007;61:156–66.
    91. Woszczek G, Chen L-Y, Nagineni S, Alsaaty S, Harry A, Logun C, i in. IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes. J Immunol Baltim Md 1950. 15 kwiecień 2007;178(8):5262–70.
    92. Sokołowska M, Kowalski ML, Pawliczak R. [Peroxisome proliferator-activated receptors-gamma (PPAR-gamma) and their role in immunoregulation and inflammation control]. Postȩpy Hig Med Dośw Online. 2005;59:472–84.
    93. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep. listopad 2005;5(6):463–71.
    94. Woszczek G, Pawliczak R, Qi H-Y, Nagineni S, Alsaaty S, Logun C, i in. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure. J Immunol Baltim Md 1950. 15 październik 2005;175(8):5152–9.